Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Patent
1990-04-24
1995-11-28
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
53038822, 4241381, 4241411, 4241431, 424 91, A61K 5110, A61K 39395, C07K 1630
Patent
active
054705711
ABSTRACT:
Monoclonal antibody 425 having properties particularly beneficial for anti-tumor therapy has been raised. MAb 425 antibody binds to EGF-receptors and inhibits their bioactivities. The amount of binding of the antibody to cancer cells can be increased by treatment of the cells with lymphokine preparations. Radiolabeled MAb 425 is used for treatment of EGF receptor-expressing gliomas.
REFERENCES:
Gooi et al, Molecular Immunology, 1985, vol. 22, pp. 689-693.
Gooi, Bioscience Reports, 1983, vol. 3, pp. 1045-1052.
Gooi et al, Bioscience Reports, 1985, vol. 5, pp. 83-94.
Le Pendu et al, Carbohydrate Research, 1985, vol. 141, pp. 347-349.
Parker et al, Journal of Biological Chemistry, 1984, vol. 259, pp. 9906-9912.
Richert et al, Federation Proceedings, 1983, vol. 42, p. 1904, Abstract No. 859.
Kawamoto et al, Proceedings of the National Academy of Sciences USA, 1983, vol. 80, pp. 1337-1341.
Fernandez-Pol, Journal of Biological Chemistry, 1985, vol. 260, pp. 5003-5011.
Schreiber et al, Journal of Biological Chemistry, 1983, vol. 258, pp. 846-853.
Koprowski et al, Somatic Cell and Molecular Genetics, 1985, vol. 11, pp. 297-302.
Parsons Chandler et al, J. Biol. Chem., 1988, vol. 260, pp. 3360-3362.
Greiner et al, Science, 1987, vol. 235, pp. 895-898.
Fellous et al, European Journal of Immunology, 1979, vol. 9, pp. 446-449.
Greiner et al, Cancer Research, 1984, vol. 44, pp. 3208-3214.
Cohen et al, Journal of Biological Chemistry, 1982, vol. 257, pp. 1523-1531.
Haigler et al, Biochimica et Biophysica Acta, 1980, vol. 598, pp. 314-325.
Libermann et al, Cancer Research, 1984, vol. 44, pp. 753-760.
Ullrich et al, Nature, 1984, vol. 309, pp. 418-425.
Rodeck et al, Cancer Research, 1987, vol. 47, pp. 3692-3696.
Takahashi et al, Cancer Research, 1987, vol. 47, pp. 3847-3850.
Basu et al, Cancer Research, 1987, vol. 47, pp. 2531-2536.
Schreiber et al, Proceedings of the National Academy of Sciences USA, 1981, vol. 78, pp. 7535-7539.
Waterfield et al, Journal of Cellular Biochemistry, 1982, vol. 20, pp. 149-161.
Liebermann et al., J. Cell Science Supplement, 1985, vol. 3, pp. 161-172.
Sato et al. Mol. Biol. Med. 1: 511-529 1983.
Masui et al. Cancer Res 44: 1002-1007 1984.
Murthy et al. Fed Proc. 45(6) 1574 1986.
Palombella et al. Biosis AN: BA83:95900; J Biol Chem 262(5) 1950-1954 1987.
Bernstein et al. Proc. Am. Assoc. Cancer Res Ann Mtg vol. 28(0) 1987 p. 24.
Epenetos et al. British Med. J. 290:1463-66, 1985.
Murthy et al. Arch Biochem Biophys 252(2): 549-60 1987.
Houghton et al. Seminars in Oncology 13: 165-179, 1986.
Brody et al. Radiat. Ther. Oncol. 24:151-160, 1990.
Harris et al. Tibtech vol. 11:42-44, 1993.
Dorland's Illustrated Medical Dictionary, 25th Ed., W. B. Saunders, Publ. 1965, p. 651.
DeNardo et al. J. Radiation Oncol. Biol. Phys. 11:335-48, 1985.
Wessels et al. Med Phys. 11:638-645, 1984.
Sehlom, Ch6 in "Molecular Foundations of Oncology", Broder, Ed., Williams & Wilkins Publ., 1991 pp. 95-134.
Herlyn Meenhard
Rodeck Ulrich
Hutzell Paula K.
The Wistar Institute
LandOfFree
Method of treating human EGF receptor-expressing gliomas using r does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating human EGF receptor-expressing gliomas using r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating human EGF receptor-expressing gliomas using r will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2011734